Early Aortic Valve Intervention Not Beneficial for Severe Aortic Stenosis
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 31, 2024 -- For patients with asymptomatic severe aortic stenosis and myocardial fibrosis, early aortic valve intervention does not impact all-cause death or unplanned aortic stenosis-related hospitalization compared with guideline-directed conservative management, according to a study published online Oct. 28 in the Journal of the American Medical Association to coincide with the annual Transcatheter Cardiovascular Therapeutics conference, held from Oct. 27 to 30 in Washington, D.C.
Krithika Loganath, M.D., from the University of Edinburgh in the United Kingdom, and colleagues examined whether early valve intervention reduced the incidence of all-cause death or unplanned aortic stenosis-related hospitalization in asymptomatic patients with severe aortic stenosis and myocardial fibrosis in a trial conducted at 24 cardiac centers. A total of 224 eligible patients were enrolled and randomly assigned to receive early valve intervention with transcatheter or surgical aortic valve replacement or guideline-directed conservative management (113 and 111 patients, respectively).
The researchers found that the primary end point (composite of all-cause death or unplanned aortic stenosis-related hospitalization) occurred in 18 and 23 percent of patients in the early intervention and guideline-directed conservative management groups, respectively (hazard ratio [HR], 0.79; 95 percent confidence interval [CI], 0.44 to 1.43). No significant difference was seen in seven of nine prespecified secondary end points. All-cause death occurred in 14 and 13 percent of patients in the early-intervention and guideline-directed groups, respectively (HR, 1.22; 95 percent CI, 0.59 to 2.51). Unplanned aortic stenosis hospitalization occurred in 6 and 17 percent, respectively (HR, 0.37; 95 percent CI, 0.16 to 0.88).
"There was no demonstrable difference in the primary composite end point of all-cause mortality or unplanned aortic stenosis-related hospitalization," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
WEDNESDAY, June 18, 2025 -- In coastal counties, marine microplastic levels (MMLs) are associated with the prevalence of cardiometabolic diseases, according to a study published...
Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
WEDNESDAY, June 18, 2025 -- Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online...
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
WEDNESDAY, June 11, 2025 -- A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.